Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature

To compare comprehensiveness and accuracy of drug interaction information in the German summary of product characteristics (SPC) with current evidence from the literature and to evaluate the SPC’s usefulness with respect to management of drug interactions.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Bergk, Verena (VerfasserIn) , Haefeli, Walter E. (VerfasserIn) , Gasse, Christiane (VerfasserIn) , Brenner, Hermann (VerfasserIn) , Martin-Facklam, Meret (VerfasserIn)
Dokumenttyp:	Article (Journal)
Sprache:	Englisch
Veröffentlicht:	28 June 2005
In:	European journal of clinical pharmacology Year: 2005, Jahrgang: 61, Heft: 5, Pages: 327-335
ISSN:	1432-1041
DOI:	10.1007/s00228-005-0943-4
Online-Zugang:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00228-005-0943-4
Verfasserangaben:	Verena Bergk, Walter E. Haefeli, Christiane Gasse, Hermann Brenner, Meret Martin-Facklam

Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature von Bergk, Verena (VerfasserIn) , Haefeli, Walter E. (VerfasserIn) , Gasse, Christiane (VerfasserIn) , Brenner, Hermann (VerfasserIn) , Martin-Facklam, Meret (VerfasserIn) ,

in: European journal of clinical pharmacology, 61 (2005), Seite 327-335

Article (Journal)

Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature

Ähnliche Einträge